Patents by Inventor Ronald K. Yamamoto

Ronald K. Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100191177
    Abstract: Surgical devices are provided for aspiration of the subretinal fluid (SRF) of the eye in a retinal detachment that allows re-apposition of the sensory retina to the underlying RPE. The device is connected to a vacuum source, introduced into the posterior chamber through a sclerostomy port and placed against the detached retinal tissue. The device pulls on and captures the surface of the sensory retina, causing a micro needle to pierce through the tissue. As the sensory retina is captured and held in place by the vacuum, a protected pocket is created and the tissue is prevented from folding onto itself and occluding the micro needle tip.
    Type: Application
    Filed: January 23, 2009
    Publication date: July 29, 2010
    Applicant: iScience Interventional Corporation
    Inventors: Tom S. Chang, Friedrich Ho, Stanley R. Conston, Ronald K. Yamamoto
  • Publication number: 20100179652
    Abstract: The invention relates to a novel apparatus for the treatment of ocular disease, particularly glaucoma. The apparatus consists of a locating device to locate Schlemm's Canal within the anterior portion of the eye and a surgical tool to access the canal for treatment. The apparatus allows for guided, minimally invasive surgical access to Schlemm's Canal to enable surgical procedures to be performed on the canal and trabecular meshwork to reduce intraocular pressure. The apparatus may also deliver devices or substances to Schlemm's Canal in the treatment of glaucoma.
    Type: Application
    Filed: October 5, 2009
    Publication date: July 15, 2010
    Inventors: Ronald K. Yamamoto, Stanley R. Conston, Michael F. Nash, Paul S. Koch
  • Patent number: 7699882
    Abstract: The invention provides minimally invasive microsurgical tools and methods to form an aqueous humor shunt or bypass for the treatment of glaucoma. The invention enables surgical creation of a tissue tract (7) within the tissues of the eye to directly connect a source of aqueous humor such as the anterior chamber (1), to an ocular vein (4). The tissue tract (7) from the vein (4) may be connected to any source of aqueous humor, including the anterior chamber (1), an aqueous collector channel, Schlemm's canal (2), or a drainage bleb. Since the aqueous humor passes directly into the venous system, the normal drainage process for aqueous humor is restored. Furthermore, the invention discloses devices and materials that can be implanted in the tissue tract to maintain the tissue space and fluid flow.
    Type: Grant
    Filed: September 17, 2003
    Date of Patent: April 20, 2010
    Assignee: iScience Interventional Corporation
    Inventors: Robert Stamper, Stanley R. Conston, Ronald K. Yamamoto
  • Publication number: 20090247955
    Abstract: Injectors are provided that may be pre-filled aseptically with an active biological agent into a sterile cavity and sealed in such a manner that the injectate may be readily expelled into the body. The injectors are particularly useful for injecting precisely measured small volumes of sterile agents.
    Type: Application
    Filed: March 27, 2009
    Publication date: October 1, 2009
    Applicant: iScience Interventional Corporation
    Inventors: Ronald K. Yamamoto, Stanley R. Conston
  • Publication number: 20090081130
    Abstract: Microparticles are provided comprising a shell of an outer layer of a biologically compatible material and an inner layer of biodegradable polymer. The core of the microparticles contain a gas, liquid or solid for use in drug delivery or as a contrast agent for ultrasonic contrast imaging. The microparticles are capable of passing through the capillary systems of a subject.
    Type: Application
    Filed: December 5, 2008
    Publication date: March 26, 2009
    Applicant: Point Biomedical Corporation
    Inventors: Thomas B. Ottoboni, Robert E. Short, Ronald K. Yamamoto
  • Publication number: 20090028953
    Abstract: Compositions of microspheres formed of stabilized hyaluronic acid are disclosed. The unique biological properties of hyaluronic acid provide for very inert properties when exposed to tissues. Microsphere formulations of hyaluronic acid have medical utility due to the resultant properties of flowability, physical stability, and degradability. High concentration formulations of the microspheres have utility when injected to form a localized mass within tissues by providing physical stability and anti-fibrotic biological activity, especially suitable for certain surgical reconstructions. Low concentration formulation of the microspheres of the appropriate size range have utility when injected into the blood system to delivery diagnostic and therapeutic compounds.
    Type: Application
    Filed: September 15, 2008
    Publication date: January 29, 2009
    Inventors: Ronald K. Yamamoto, Stanley R. Conston
  • Patent number: 6902584
    Abstract: A porous three-dimensional bone grafting matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix and having a particle size of 5 microns or less.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: June 7, 2005
    Assignee: Depuy Spine, Inc.
    Inventors: Michael K. Kwan, Stephen D. Pacetti, Ronald K. Yamamoto
  • Publication number: 20040220680
    Abstract: A porous three-dimensional tissue repair matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix.
    Type: Application
    Filed: May 27, 2004
    Publication date: November 4, 2004
    Applicant: DEPUY ACROMED, INC.
    Inventors: Ronald K. Yamamoto, Michael K. Kwan, Stephen D. Pacetti
  • Patent number: 6776761
    Abstract: A composition for ultrasonic imaging is described having a microbubble population of controlled fragility. The microbubbles comprise an outer shell and a hollow core. The ratio of shell thickness to microbubble diameter is substantially similar across the population of microbubbles. A method of using such composition for imaging a fluid filled cavity, vessel or tissue is described.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: August 17, 2004
    Assignee: Point Biomedical Corporation
    Inventors: Thomas B. Ottoboni, E. Glenn Tickner, Robert E. Short, Ronald K. Yamamoto
  • Patent number: 6764517
    Abstract: A porous three-dimensional tissue repair matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: July 20, 2004
    Assignee: DePuy AcroMed, Inc.
    Inventors: Ronald K. Yamamoto, Michael K. Kwan, Stephen D. Pacetti
  • Publication number: 20040086459
    Abstract: Microparticles are provided comprising a shell of an outer layer of a biologically compatible material and an inner layer of biodegradable polymer. The core of the microparticles contain a gas, liquid or solid for use in drug delivery or as a contrast agent for ultrasonic contrast imaging. The microparticles are capable of passing through the capillary systems of a subject.
    Type: Application
    Filed: October 20, 2003
    Publication date: May 6, 2004
    Inventors: Thomas B. Ottoboni, Robert E. Short, Ronald K. Yamamoto
  • Publication number: 20030211166
    Abstract: Compositions of microspheres formed of stabilized hyaluronic acid are disclosed. The unique biological properties of hyaluronic acid provide for very inert properties when exposed to tissues. Microsphere formulations of hyaluronic acid have medical utility due to the resultant properties of flowability, physical stability, and degradability. High concentration formulations of the microspheres have utility when injected to form a localized mass within tissues by providing physical stability and anti-fibrotic biological activity, especially suitable for certain surgical reconstructions. Low concentration formulation of the microspheres of the appropriate size range have utility when injected into the blood system to delivery diagnostic and therapeutic compounds.
    Type: Application
    Filed: January 31, 2003
    Publication date: November 13, 2003
    Inventors: Ronald K Yamamoto, Stanley R. Conston
  • Publication number: 20030088256
    Abstract: The present invention provides implantable devices and associated methods for interconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprise a vessel connector and a intravascular support mechanism for establishing fluid communication between two vessels. Certain embodiments further include a sealing member for further sealing the openings in the vessels created for inserting the subject devices.
    Type: Application
    Filed: October 3, 2002
    Publication date: May 8, 2003
    Inventors: Stanley R. Conston, Ronald K. Yamamoto, Jodi J. Akin, Gitanjali V. Barry
  • Patent number: 6524608
    Abstract: Bioerodible, sustained release preparations are provided for placement into the bladder through the urethra which provided sustained release of drugs. Configurations are provided which are insertable through a catheter, such as a coiled filament, patch or a flowable gel. The device is bioeroded during or after the sustained release of the drug such that there is no blockage of the urinary tract while the device is in place within the bladder.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: February 25, 2003
    Assignee: Point Biomedical Corporation
    Inventors: Thomas B. Ottoboni, Ronald K. Yamamoto, Stanley R. Conston
  • Publication number: 20030036697
    Abstract: A composition for ultrasonic imaging is described having a microparticle population of controlled fragility. A method of using such composition for imaging a fluid filled cavity, vessel or tissue is described.
    Type: Application
    Filed: August 20, 2002
    Publication date: February 20, 2003
    Inventors: Thomas B. Ottoboni, E. Glenn Tickner, Robert E. Short, Ronald K. Yamamoto
  • Publication number: 20020183855
    Abstract: A porous three-dimensional tissue repair matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix.
    Type: Application
    Filed: February 22, 2002
    Publication date: December 5, 2002
    Inventors: Ronald K. Yamamoto, Michael K. Kwan, Stephen D. Pacetti
  • Publication number: 20020161383
    Abstract: The present invention provides implantable devices and associated methods for interconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprises at least a first segment, a second component, and a flow opening between the at least one segment and the second component when operatively used. The first segment is flexible and has physical and mechanical properties which allow it to be easily inserted into a vessel, to conformably seal with the inside wall of the vessel and to be resistant to dislodging from the vessel. The second component may comprise a second segment having the same or a similar configuration as the first segment or may be a tubular member which extends from the first segment. The first and second segments are flexible for easy insertion into an incision made within the side of each vessel.
    Type: Application
    Filed: January 18, 2002
    Publication date: October 31, 2002
    Inventors: Jodi Akin, Amr Salahieh, Michael Mack, Hani Shennib, Jackson Demond, Ronald K. Yamamoto, Stanley R. Conston
  • Patent number: 6458140
    Abstract: The present invention provides implantable devices and associated methods forinterconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprises at least a first segment, a second component, and a flow opening between the at least one segment and the second component when operatively used. The first segment is flexible and has physical and mechanical properties which allow it to be easily inserted into a vessel, to conformably seal with the inside wall of the vessel and to be resistant to dislodging from the vessel. The second component may comprise a second segment having the same or a similar configuration as the first segment or may be a tubular member which extends from the first segment. The first and second segments are flexible for easy insertion into an incision made within the side of each vessel.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 1, 2002
    Assignee: Vasconnect, Inc.
    Inventors: Jodi Akin, Amr Salahieh, Michael Mack, Hani Shennib, Jackson Demond, Ronald K. Yamamoto, Stanley R. Conston
  • Publication number: 20020072673
    Abstract: The invention relates to a novel apparatus for the treatment of ocular disease, particularly glaucoma. The apparatus consists of a locating device to locate Schlemm's Canal within the anterior portion of the eye and a surgical tool to access the canal for treatment. The apparatus allows for guided, minimally invasive surgical access to Schlemm's Canal to enable surgical procedures to be performed on the canal and trabecular meshwork to reduce intraocular pressure. The apparatus may also deliver devices or substances to Schlemm's Canal in the treatment of glaucoma.
    Type: Application
    Filed: December 11, 2000
    Publication date: June 13, 2002
    Inventors: Ronald K. Yamamoto, Stanley R. Conston, Michael F. Nash, Paul S. Koch
  • Publication number: 20010044631
    Abstract: The present invention provides implantable devices and associated methods for interconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprises at least a first segment, a second component, and a flow opening between the at least one segment and the second component when operatively used. The first segment is flexible and has physical and mechanical properties which allow it to be easily inserted into a vessel, to conformably seal with the inside wall of the vessel and to be resistant to dislodging from the vessel. The second component may comprise a second segment having the same or a similar configuration as the first segment or may be a tubular member which extends from the first segment. The first and second segments are flexible for easy insertion into an incision made within the side of each vessel.
    Type: Application
    Filed: January 26, 2001
    Publication date: November 22, 2001
    Inventors: Jodi Akin, Amr Salahieh, Michael Mack, Hani Shennib, Jackson Demond, Ronald K. Yamamoto, Stanley R. Conston